What is Agenus Inc (AGEN) stock price today?

Agenus Inc (AGEN) currently trades at $3.84 per share. The stock has a market capitalization of $147.45M and a P/E ratio of 0.00x.

Is AGEN stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Agenus Inc has a Smart Value Score of 48/100 (Grade C), resulting in a "Sell" investment rating. The Piotroski F-Score is 4/9 and Altman Z-Score is -14.23.

What is Agenus Inc's revenue and earnings?

Agenus Inc has trailing twelve-month (TTM) revenue of $114.20M with profit margins of 0.10%. Earnings per share (EPS) is $0.00.

Is Agenus Inc financially healthy?

Agenus Inc's Piotroski F-Score is 4/9 (moderate financial health). The Altman Z-Score of -14.23 places it in the distress.

AGEN

Agenus Inc

NASDAQ: AGEN · HEALTHCARE · BIOTECHNOLOGY

$3.84

-1.29% today

Updated 2026-04-29

Market cap

$147.45M

P/E ratio

0.00

P/S ratio

1.29x

EPS (TTM)

$0.00

Dividend yield

—

52W range

$3 – $7

Volume

0.8M

Market cap

$147.45M

P/E ratio

0.00

P/S ratio

1.29x

EPS (TTM)

$0.00

Dividend yield

—

52W range

$3 – $7

Volume

0.8M

WallStSmart proprietary scores

out of 100

Grade: C

Sell

Investment rating

6.0

Growth

5.0

Quality

C+

4.5

Profitability

5.3

Valuation

C+

4/9

Piotroski F-Score

Moderate

-14.2

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$15.50

+303.65%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy2 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 27.50% QoQ

+ Debt/equity -0.17x — low leverage

Risks

- Altman Z -14.23 — distress zone

- Thin margins at 0.10%

- Negative free cash flow $-17.20M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$98.02M	$156.31M	$103.46M	$114.20M	$114.20M
Net income	$-220.07M	$-245.76M	$-227.21M	$115000.00	$-10.58M
EPS	—	—	—	—	$0.00
Free cash flow	$-228.44M	$-234.16M	$-158.89M	$-158.89M	$-17.20M
Profit margin	-224.51%	-157.22%	-219.61%	0.10%	0.10%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
AGEN	$147.45M	48	6.0	4.5	5.3	5.0	—	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Agenus Inc trades at $3.84. Our Smart Value Score of 48/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -14.23, it sits in the distress. TTM revenue stands at $114.20M. with profit margins at 0.10%.

Frequently asked questions

What is Agenus Inc's stock price?

Agenus Inc (AGEN) trades at $3.84.

Is Agenus Inc overvalued?

Smart Value Score 48/100 (Grade C, Sell).

What is the price target of Agenus Inc (AGEN)?

The analyst target price is $15.50, representing +303.6% upside from the current price of $3.84.

What is Agenus Inc's revenue?

TTM revenue is $114.20M.

Piotroski F-Score?

4/9 — moderate financial health.

Altman Z-Score?

-14.23 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.agenusbio.com

Quick metrics

P/S ratio1.29x

ROE-1,279.00%

Beta1.61

50D MA$3.64

200D MA$4.04

Shares out0.04B

Float0.04B

Short ratio—

Avg volume0.8M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

AGEN vs LLY →AGEN vs JNJ →AGEN vs ABBV →Stock screener →